Diafarma is a pharmaceutical exporter established in Istanbul, Turkey, in 2003.
The company holds a pharmaceutical export license, and its activities are regularly inspected by the Ministry of Health. Its areas of focus include anti-cancer, anti-tumor and generic drugs; infectious and cardiovascular diseases; skin care products; dermatology; and oncology.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company’s stated scope includes drugs, pharmaceuticals, medical equipment, insulin pen needles, glucose test strips, glucose meters, dermal fillers, and international-origin products.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.Snapshot: September 19, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 15, 2026, September 16, 2026, September 17, 2026, September 18, 2026, September 19, 2026, September 27, 2026, October 7, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.